Preview

Современная ревматология

Расширенный поиск

Эторикоксиб (аркоксиа) в ревматологии

https://doi.org/10.14412/1996-7012-2011-671

Аннотация

В статье представлена информация о селективном ингибиторе ЦОГ 2 эторикоксибе, зарегистрированном для применения во многих странах мира. Дано краткое описание некоторых ключевых исследований, посвященных эффективности и переносимости эторикоксиба в ревматологии.

Литература

1. <div><p>Patrignani P., Capone M., Tacconelli S. Clinical pharmacology of etoricoxib: a novel selective COX2 inhibitor. Expert Opin Pharmacother 2003; 4(2): 265-84.</p><p>Martina S., Vesta K., Ripley T. Etoricoxib: a highly selective COX-2 inhibitor. Ann Pharmacother 2005; 39(5): 854-62.</p><p>Brooks P., Kubler P. Etoricoxib for arthritis and pain management. Ther Clin Risk Manag 2006; 2(1): 45-57.</p><p>Zacher J., Feldman D., Gerli R. et al. A comparison of the therapeutic efficacy and tolerability of Etoricoxib and Diclofenac in patients with osteoarthritis. Curr Med Res Opin 2003; 19(8): 725-36.</p><p>Wiesenhutter C.W., Boice J.A., Ko A. et al. A comparison of the therapeutic efficacy of Etoricoxib and Ibuprofen in patients with osteoarthritis: randomized, double-blind, placebo-controlled trial. Mayo Clin Proc 2005; 80: 470-9.</p><p>Collantes E., Curtis S.P., Lee K.W. et al. International randomized controlled study of etoricoxib in rheumatoid arthritis. BMC Fam Pract 2002; 3: 10.</p><p>Van der Heijde D., Baraf H., Ramos-Remus C. et al. Evaluation of the efficacy of etoricoxib in ankylosing spondylitis: results of a fifty-two-week, randomized, controlled study. Arthr Rheum 2005; 52(4): 1205-15.</p><p>Schumacher H., Boice J., Dahikh D. et al. Randomised double blind trial of etoricoxib and indomethacin in treatment of acute gouty arthritis. BMJ 2002; 324: 1488-92.</p><p>Pallay R.M., Seger W., Adler J.L. et al. Etoricoxib reduced pain and disability and improved quality of life in patients with chronic low back pain: a 3 month, randomized, controlled trial. Scand J Rheumatol 2004; 33: 257-66.</p><p>Birbara C.A., Puopolo A.D., Munoz D.R. et al. Treatment of chronic low back pain with etoricoxib, a new cyclooxygenase-2 selective inhibitor: improvement in pain and disability - a randomized, placebo-controlled, 3-month trial. J Pain 2003; 4: 307-15.</p><p>Boonriong T., Tangtrakulwanich B., Glablay P. et al. Comparing Etoricoxib and Celecoxib for preemptive analgesia for acute postoperative pain in patients undergoing arthroscopic anterior cruciate ligament reconstruction: a randomized controlled trial. BMC Musculoskeletal Dis 2010; 11: 246.</p><p>Siddiqui A., Sadat-Ali M., Al-Ghamdi A. et al. The effect of etoricoxib premedication on postoperative analgesia requirement in orthopedic and trauma patients. Saudi Med J 2008; 29(7): 966-70.</p></div><br />


Для цитирования:


Кудаева Ф.М., Барскова В.Г., Kudayeva F.M., Барскова В.Г. Эторикоксиб (аркоксиа) в ревматологии. Современная ревматология. 2011;5(2):61-64. https://doi.org/10.14412/1996-7012-2011-671

For citation:


Kudaeva F.M., Barskova V.G., Kudayeva F.M., Barskova V.G. Etoricoxib (arcoxia) in rheumatology. Modern Rheumatology Journal. 2011;5(2):61-64. (In Russ.) https://doi.org/10.14412/1996-7012-2011-671

Просмотров: 2173


Creative Commons License
Контент доступен под лицензией Creative Commons Attribution 4.0 License.


ISSN 1996-7012 (Print)
ISSN 2310-158X (Online)